1. Home
  2. BBNX
  3. BBNX News

Latest Beta Bionics Inc. Common Stock (BBNX) News on July 12, 2025

Abvance Therapeutics Secures Strategic Seed Financing & Leadership Expansion at ADA Scientific Sessions
BBNX

GlobeNewswire

18 days ago

Abvance Therapeutics Secures Strategic Seed Financing & Leadership Expansion at ADA Scientific Sessions

ADA takeaways: Diabetes tech firms preview new patch pumps, glucose sensors
BBNX

MedTech Dive

18 days ago

ADA takeaways: Diabetes tech firms preview new patch pumps, glucose sensors

BBNX Stock May Gain From Abbott Deal to Advance iLet Integration
BBNX

Zacks

19 days ago

BBNX Stock May Gain From Abbott Deal to Advance iLet Integration

5 things to watch at the ADA’s Scientific Sessions
BBNX

MedTech Dive

22 days ago

5 things to watch at the ADA’s Scientific Sessions

Beta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with Abbott’s Future Dual Glucose-Ketone Sensor
BBNX

GlobeNewswire

23 days ago

Beta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with Abbott’s Future Dual Glucose-Ketone Sensor

BBNX

Investing.com

a month ago

Truist starts on diabetes device makers, sees glucose monitor, insulin pump growth

BBNX

MT Newswires

a month ago

Truist Securities Initiates Beta Bionics at Buy With $26 Price Target

Beta Bionics CEO, CFO on how to take a company public
BBNX

MedTech Dive

a month ago

Beta Bionics CEO, CFO on how to take a company public

BBNX

MT Newswires

a month ago

Goldman Sachs Initiates Coverage on Beta Bionics With Neutral Rating, $16 Price Target

BBNX

MT Newswires

a month ago

Wolfe Research Initiates Coverage on Beta Bionics With Outperform Rating, $20 Price Target

The medtech IPO window is finally open. Or is it?
BBNX

MedTech Dive

a month ago

The medtech IPO window is finally open. Or is it?

BBNX

GuruFocus.com

2 months ago

Beta Bionics Inc (BBNX) Q1 2025 Earnings Call Highlights: Strong Sales Growth and Strategic ...

Beta Bionics Reports First Quarter 2025 Financial Results and Raises Annual Guidance for Full Year 2025
BBNX

GlobeNewswire

2 months ago

Beta Bionics Reports First Quarter 2025 Financial Results and Raises Annual Guidance for Full Year 2025

Beta Bionics to Present at the Bank of America Securities Health Care Conference
BBNX

GlobeNewswire

2 months ago

Beta Bionics to Present at the Bank of America Securities Health Care Conference

Beta Bionics to Announce First Quarter 2025 Financial Results on May 6, 2025
BBNX

GlobeNewswire

3 months ago

Beta Bionics to Announce First Quarter 2025 Financial Results on May 6, 2025

Beta Bionics to Host Investor Event on June 22, 2025
BBNX

GlobeNewswire

3 months ago

Beta Bionics to Host Investor Event on June 22, 2025

Newly public Beta Bionics reports sales surge; Dexcom hires CCO
BBNX

MedTech Dive

3 months ago

Newly public Beta Bionics reports sales surge; Dexcom hires CCO

Beta Bionics Announces Board Appointment of Gerard Michel
BBNX

GlobeNewswire

3 months ago

Beta Bionics Announces Board Appointment of Gerard Michel

BBNX

MT Newswires

4 months ago

Beta Bionics Reports Q4 Loss as Sales Rise; Sets 2025 Revenue Guidance

Beta Bionics Announces Fourth Quarter and Full Year 2024 Financial Results and Introduces Annual Guidance for Full Year 2025
BBNX

GlobeNewswire

4 months ago

Beta Bionics Announces Fourth Quarter and Full Year 2024 Financial Results and Introduces Annual Guidance for Full Year 2025

Beta Bionics, Inc. (BBNX): Among Stocks With At Least $10 Million In Insider Spending Recently
BBNX

Insider Monkey

4 months ago

Beta Bionics, Inc. (BBNX): Among Stocks With At Least $10 Million In Insider Spending Recently

Beta Bionics to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025
BBNX

GlobeNewswire

5 months ago

Beta Bionics to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025

Palantir initiated, Roku upgraded: Wall Street’s top analyst calls
BBNX

TipRanks

5 months ago

Palantir initiated, Roku upgraded: Wall Street’s top analyst calls

BBNX

MT Newswires

5 months ago

Baird Initiates Beta Bionics at Neutral With $20 Price Target

Beta Bionics Announces Closing of $234.6 Million Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
BBNX

GlobeNewswire

5 months ago

Beta Bionics Announces Closing of $234.6 Million Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Beta Bionics raises $204M in IPO
BBNX

MedTech Dive

5 months ago

Beta Bionics raises $204M in IPO

Beta Bionics raises $204m to kickstart medtech IPO season
BBNX

Medical Device Network

5 months ago

Beta Bionics raises $204m to kickstart medtech IPO season

BBNX

MT Newswires

5 months ago

Beta Bionics Shares Rise in Nasdaq Debut

Beta Bionics Announces Pricing of Upsized $204 Million Initial Public Offering
BBNX

GlobeNewswire

5 months ago

Beta Bionics Announces Pricing of Upsized $204 Million Initial Public Offering

Share on Social Networks: